Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

CareRx Corp. buy krebskrebs

Start price
€1.59
13.06.23 / 50%
Target price
€2.00
13.06.24
Performance (%)
-13.21%
End price
€1.38
14.06.24
Summary
This prediction ended on 14.06.24 with a price of €1.38. The price of CareRx Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.21%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
CareRx Corp. -1.504% -1.504% -10.274%
iShares Core DAX® 2.821% -1.953% 15.071%
iShares Nasdaq 100 5.285% -5.092% 29.254%
iShares Nikkei 225® 3.687% -4.221% 14.286%
iShares S&P 500 3.577% -2.240% 25.546%

Comments by krebskrebs for this prediction

In the thread CareRx Corp. diskutieren
Prediction Buy
Perf. (%) -13.21%
Target price 2.000
Change
Ends at

Buy mit Kursziel 2,0

In the thread Trading CareRx Corp.
Prediction Buy
Perf. (%) -13.21%
Target price 2.000
Change
Ends at 13.06.24

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten